Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of SPG7 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of SPG7 mRNA | affects expression | 21346803
|
D004052 |
Diethylnitrosamine |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of SPG7 mRNA | affects cotreatment|increases expression | 16158176
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of SPG7 mRNA | affects cotreatment|increases expression | 14656948
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SPG7 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of SPG7 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPG7 mRNA | affects cotreatment|increases expression | 17942748
|
D015073 |
2-Acetylaminofluorene |
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of SPG7 mRNA | affects cotreatment|increases expression | 16158176
|
D015073 |
2-Acetylaminofluorene |
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of SPG7 mRNA | affects cotreatment|increases expression | 14656948
|
D016627 |
Oxidopamine |
Oxidopamine results in increased expression of SPG7 protein | increases expression | 19763263
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SPG7 mRNA | increases expression | 18301758
|
D012643 |
Selenium |
Selenium results in increased expression of SPG7 mRNA | increases expression | 19244175
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of SPG7 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPG7 mRNA | affects cotreatment|increases expression | 17942748
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of SPG7 mRNA | affects expression | 21346803
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.76 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.22 | 11752688 15322242 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
9.22 | 7525203 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.16 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.27 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.84 | 14692618 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
7.29 | 10737359 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.29 | 10737359 6695378 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
6.23 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
18.46 | 18056438 16434500 17620307 19061943 17162532 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
18.46 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.46 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.64 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.74 | 15885639 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Oxidopamine |
4.74 | 14699433 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.24 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.24 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.82 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.82 | 20390343 18984771 18815881 16873071 19221464 20065188 15565566 19244106 19011961 18855134 17893378 17242785 19189210 19103187 15668708 19059307 19155303 20005174 17049068 19066611 21152245 18997820 17261762 18425577 18629630 18821012 19084267 21138602 11161223 16273361 20859285 19142967 20544844 16818667 19288272 19410462 20135344 19289846 17440819 16202921 19200415 19115204 18351453 19487384 19189212 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.82 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.68 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
9.10 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
9.10 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
9.10 | 17761372 6705139 3581430 10737359 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
9.10 | 16878318 20084675 16779866 19919837 20101231 3084413 16502159 18210153 11831363 17761372 19418558 19701751 16569478 19394651 20512989 18788625 16328049 16288022 19208518 18506893 20727157 20935162 18665156 19519916 19822196 17428255 16698587 17138121 16935385 16807293 10737359 18785209 16830150 20524982 16540662 19052882 18978308 18393292 20214788 19171122 21159647 19539802 18056438 17173139 19335982 17978847 18691550 3581430 16681979 10672840 18494052 20432363 20007298 18971187 20514400 19383236 19107877 17055752 17162532 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
9.10 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.75 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
3.95 | 15817613 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.01 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.01 | 2727394 7505956 21159647 17174075 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.74 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.74 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.09 | 15861022 17681005 17333356 11677210 17110522 16105132 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.09 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 12621046 8697196 15340226 16354765 15668235 |
MESH:D003092 |
Colitis |
|
Selenium |
3.95 | 17936198 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.69 | 17141729 14669216 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
9.69 | 15095906 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
19.88 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
19.88 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
19.88 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.54 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.48 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.32 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.32 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.60 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
15.78 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
15.78 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
15.78 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
15.78 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
15.78 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
15.78 | 21346803 18551238 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.00 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.00 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.49 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.49 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.13 | 20544844 16202921 17893378 19155303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.33 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
19.96 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
19.96 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
19.96 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
19.96 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.31 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.72 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.38 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.12 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.40 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.22 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.22 | 17162251 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
5.53 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
4.54 | 6705139 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.55 | 19176532 18467677 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.55 | 12621046 16120746 15340226 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
15.55 | 15817613 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 18606429 16354765 15340226 16959395 8697196 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.31 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.95 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.98 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.61 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.20 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
7.20 | 12150543 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.67 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.67 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.67 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.41 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.72 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.02 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.11 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.11 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
13.11 | 18625569 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.25 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.89 | 18407596 20032147 18665156 18522880 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.46 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.46 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.46 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.13 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
18.63 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
18.63 | 18001218 11376686 16273603 10672840 14678523 10737359 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
18.63 | 21071580 19256749 20501860 19690152 19255062 19638242 21167192 19426721 19551842 19812893 18648771 18754104 19833225 20492335 15175105 20405173 20434301 10737359 20583210 21278145 19850985 19499222 19996281 12771043 19090486 12112319 2862719 9163691 19254457 20452335 21047994 18644402 19642983 20137499 20101389 19427195 15885732 19294768 19073162 2422723 16942905 18978307 20118626 18977376 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
18.63 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
18.63 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
18.63 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.85 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
14.85 | 6150874 1399818 534488 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
14.85 | 9362446 18079962 2563599 18253720 17854601 17942915 3124819 18775883 18308698 19009564 18093689 16267830 19539802 18544905 16842330 18164116 19004024 19126423 19519916 18282651 21159647 17174075 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.85 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
4.99 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
4.99 | 20512841 21163286 20970405 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.99 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.99 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.95 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.33 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.33 | 19196722 14580682 19196723 11731420 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.76 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.90 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.38 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.84 | 15107826 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.68 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.19 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.05 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
18.97 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
18.97 | 7678174 18551238 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
18.97 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.90 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.90 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.55 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.01 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.22 | 19196722 19189210 19200415 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
9.27 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Oxidopamine |
9.27 | 18514411 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.33 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
15.98 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
15.98 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
15.98 | 14694615 17852074 12819281 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.46 | 16540662 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.84 | 11578682 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Oxidopamine |
5.63 | 15893579 11771942 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.11 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.68 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11399792 11896295 11118676 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.12 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.51 | 16919318 15861022 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.45 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.46 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.46 | 18551238 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
10.46 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.10 | 16192470 |
OMIM:607259 |
SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE |
marker/mechanism |
|
| |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.30 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.30 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.23 | 19457130 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
5.38 | 15817613 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.77 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.28 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.09 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
12.38 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
12.38 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
12.38 | 15867355 15289314 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
12.38 | 16712894 17572228 8653321 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.65 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.65 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.46 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.68 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |